Generate Biomedicines
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer (NCT07484022) | Generate Biomedicines | 2026-06-01 |
| A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2) (NCT07359846) | Generate Biomedicines | 2026-01-20 |
| A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1) (NCT07276724) | Generate Biomedicines | 2025-12-03 |
| Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy Adult Participants (NCT06920693) | Generate Biomedicines | 2025-03-27 |
| A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD (NCT07116889) | Generate Biomedicines | 2023-12-12 |
| Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-0669 in Healthy Adult Participants (NCT07050511) | Generate Biomedicines | 2023-07-18 |
Track Generate Biomedicines automatically
Every clearance here is in the API, with alerts when new ones post.